Skip to content

NT FARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

NT FARMA

BE 0783.941.726
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€8,982
2024 · €32,839-€23,858
Equity
€66,224
2024 · €58,002+€8,223
Cash
€42,996
2024 · €17,642+€25,354
Balance sheet total
€82,119
2024 · €72,312+€9,807

Largest movements

2024 to 2025
Assets
  • Cash +€25,354

    up €25,354 (+144%), from €17,642 to €42,996

    mainly Current investments (+€10,000) and Net result for the year (+€8,982)

  • Current investments -€10,000

    down €10,000 (-33.3%), from €30,000 to €20,000

  • Receivables within one year -€4,377

    down €4,377 (-24.2%), from €18,056 to €13,679

    of which Other amounts receivable: -€4,989

  • Tangible fixed assets -€839

    down €839 (-56.8%), from €1,476 to €637

Equity and liabilities
  • Reserves +€8,223

    up €8,223 (+14.3%), from €57,502 to €65,724

  • Trade debts +€826

    up €826 (+25,187%), from €3 to €829

Income statement
  • Gross operating margin -€27,625

    down €27,625 (-64.9%), from €42,555 to €14,929

  • Taxes -€5,720

    down €5,720 (-65.6%), from €8,725 to €3,006

  • Financial charges +€1,917

    up €1,917 (+2,551%), from €75 to €1,992

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €32,839
Gross operating margin -€27,625
Depreciation -€140
Other operating charges -€159
Financial income +€264
Financial charges -€1,917
Taxes +€5,720
Result 2025 €8,982
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€16,691
Investment +€9,422
Financing -€759
Cash 2024 €17,642
Net result for the year +€8,982
Depreciation +€1,416
Stocks and contracts +€332
Receivables within one year +€4,377
Deferred charges and accrued income -€0
Trade debts +€826
Tax, wage and social debts +€699
Other debts +€59
Investment in fixed assets (net) -€578
Current investments +€10,000
Contributions, distributions and other -€759
Cash 2025 €42,996
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €72,312 €82,119 +€9,807 +13.6%
Fixed assets 21/28 €1,476 €637 -€839 -56.8%
Tangible fixed assets 22/27 €1,476 €637 -€839 -56.8%
Furniture and vehicles 24 €1,476 €637 -€839 -56.8%
Current assets 29/58 €70,836 €81,482 +€10,646 +15.0%
Stocks and contracts in progress 3 €5,081 €4,750 -€332 -6.5%
Stocks 30/36 €5,081 €4,750 -€332 -6.5%
Amounts receivable within one year 40/41 €18,056 €13,679 -€4,377 -24.2%
Trade receivables 40 €10,975 €11,586 +€611 +5.6%
Other amounts receivable 41 €7,082 €2,093 -€4,989 -70.4%
Current investments 50/53 €30,000 €20,000 -€10,000 -33.3%
Cash at bank and in hand 54/58 €17,642 €42,996 +€25,354 +144%
Deferred charges and accrued income 490/1 €57 €57 +€0 +0.6%
Total equity and liabilities 10/49 €72,312 €82,119 +€9,807 +13.6%
Equity 10/15 €58,002 €66,224 +€8,223 +14.2%
Contributions 10/11 €500 €500 = 0.0%
Contributions outside capital 11 €500 €500 = 0.0%
Other 1109/19 €500 €500 = 0.0%
Reserves 13 €57,502 €65,724 +€8,223 +14.3%
Distributable reserves 133 €57,502 €65,724 +€8,223 +14.3%
Amounts payable 17/49 €14,310 €15,895 +€1,585 +11.1%
Amounts payable within one year 42/48 €14,310 €15,895 +€1,585 +11.1%
Trade debts 44 €3 €829 +€826 +25,187%
Suppliers 440/4 €3 €829 +€826 +25,187%
Taxes, remuneration and social security 45 €13,607 €14,306 +€699 +5.1%
Taxes 450/3 €13,607 €11,306 -€2,301 -16.9%
Remuneration and social security 454/9 - €3,000 +€3,000
Other amounts payable 47/48 €700 €759 +€59 +8.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,276 €1,416 +€140 +11.0%
Other operating charges 640/8 - €159 +€159
Gross operating margin 9900 €42,555 €14,929 -€27,625 -64.9%
Operating profit (loss) 9901 €41,279 €13,354 -€27,925 -67.6%
Financial income 75/76B €361 €625 +€264 +73.3%
Recurring financial income 75 €361 €625 +€264 +73.3%
Financial charges 65/66B €75 €1,992 +€1,917 +2,551%
Recurring financial charges 65 €75 €1,992 +€1,917 +2,551%
Profit (loss) for the period before taxes 9903 €41,565 €11,987 -€29,577 -71.2%
Income taxes 67/77 €8,725 €3,006 -€5,720 -65.6%
Profit (loss) for the period 9904 €32,839 €8,982 -€23,858 -72.6%
Profit (loss) for the period to be appropriated 9905 €32,839 €8,982 -€23,858 -72.6%

Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.